These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37311667)

  • 61. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review.
    Ha AH; Ham I; Nair GM; Connolly SJ; Dorian P; Morillo CA; Healey JS
    Heart Rhythm; 2012 Dec; 9(12):2068-74. PubMed ID: 23108056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis.
    Nso N; Nassar M; Lakhdar S; Enoru S; Guzman L; Rizzo V; Munira MS; Radparvar F; Thambidorai S
    Int J Cardiol; 2022 Feb; 349():62-78. PubMed ID: 34801615
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators.
    Reeder HT; Shen C; Buxton AE; Haneuse SJ; Kramer DB
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005675. PubMed ID: 31412732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression.
    Varghese S; Geller JC; Ohlow MA
    Herzschrittmacherther Elektrophysiol; 2019 Sep; 30(3):306-312. PubMed ID: 31440897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Manual for the psychotherapeutic treatment of acute and post-traumatic stress disorders following multiple shocks from implantable cardioverter defibrillator (ICD).
    Jordan J; Titscher G; Peregrinova L; Kirsch H
    Psychosoc Med; 2013; 10():Doc09. PubMed ID: 24403967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
    Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
    Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.
    Undavia M; Goldstein NE; Cohen P; Sinthawanarong K; Singson M; Bhutani D; Munson T; Gomes JA; Fischer A; Mehta D
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1411-8. PubMed ID: 18950298
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of patients' age at implantation on mortality and defibrillator shocks.
    Saba S; Adelstein E; Wold N; Stein K; Jones P
    Europace; 2017 May; 19(5):802-807. PubMed ID: 27256416
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implantable cardioverter-defibrillators in cardiac transplant recipients: A systematic review from the Electrophysiology Collaborative Consortium for Meta-analysis-ELECTRAM investigators.
    Garg J; Shah K; Turagam MK; Tzou W; Gopinathannair R; Natale A; Lakkireddy D
    Pacing Clin Electrophysiol; 2020 Dec; 43(12):1529-1537. PubMed ID: 33180346
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of appropriate shock after generator replacement in patients with an implantable cardioverter defibrillator.
    Arcinas LA; Chew DS; Seifer CM; Baranchuk A; Supel I; Exner DV; Boles U; McIntyre WF
    Pacing Clin Electrophysiol; 2021 May; 44(5):911-918. PubMed ID: 33826179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation.
    Hegel MT; Griegel LE; Black C; Goulden L; Ozahowski T
    Int J Psychiatry Med; 1997; 27(1):57-69. PubMed ID: 9565714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
    Sueda S; Kohno H
    Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cognitive behavioural therapy significantly reduces anxiety in patients with implanted cardioverter defibrillator compared with usual care: Findings from the Screen-ICD randomised controlled trial.
    Berg SK; Rasmussen TB; Herning M; Svendsen JH; Christensen AV; Thygesen LC
    Eur J Prev Cardiol; 2020 Feb; 27(3):258-268. PubMed ID: 31575299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
    Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality.
    Pedersen SS; VAN DEN Berg M; Erdman RA; VAN Son J; Jordaens L; Theuns DA
    Pacing Clin Electrophysiol; 2009 Feb; 32(2):184-92. PubMed ID: 19170907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.